BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Bristol Myers Squibb Acquires Karuna Therapeutics for $14 Billion

KarXT Is a Potential First-in-Class Treatment for Schizophrenia and as an Adjunctive Therapy, and First-in-Disease Treatment for Alzheimer’s Di...

December 26, 2023 | News

Astellas Completes Acquisition of Propella Therapeutics

Through the acquisition of Propella, Astellas has acquired PRL-02 (abiraterone decanoate), a next-generation androgen biosynthesis inhibitor being develope...

December 22, 2023 | News

Juniper Therapeutics Secures Exclusive SAR Registration Rights for COVID-19 Drug from Ping An-Shionogi HK in Singapore

Singapore-headquartered Juniper Therapeutix, a science-led healthcare company focused on commercializing novel therapies, announced its agreement with...

December 22, 2023 | News

CellOrigin Treats First CAR-M Patient in China, Unveils Second-Gen CAR-M for Solid Tumors

"A single center, single-arm, dose-escalation, exploratory clinical trial to examine the safety, tolerability, pharmacokinetics and prelimina...

December 21, 2023 | News

EpiVax Grants ISPRI Toolkit License to Eisai for Preclinical Immunogenicity Screening

The ISPRI toolkit is a secure web-based platform that allows researchers to rapidly assess the immunogenic risk of biologic candidates. The fu...

December 21, 2023 | News

InxMed Licenses Next-Gen ADCs with Escugen

The license agreement provides InxMed with right to use EZWi-Fit® platform on the several novel ADC candidate molecules. InxMed will hav...

December 20, 2023 | News

NUS Researchers in Singapore Innovate Flexible Method for Immune Cell Study

Our body's immune system is a complex network of organs, cells, and proteins that work in synchrony to protect our bodies against infections caused by path...

December 19, 2023 | News

Illumina Announces Decision to Divest GRAIL

The divestiture will be executed through a third-party sale or capital markets transaction, consistent with the European Commission's divestiture o...

December 18, 2023 | News

GeneQuantum and BioMap Collaborate on Next-Gen ADC Therapeutics

The partnership will combine GQ's proprietary enzymatic site-specific conjugation technology platforms (iLDC® and iGDC®), linker-payload platform, ...

December 18, 2023 | News

Nona Biosciences and Pfizer Strike Global Deal for MSLN-Targeted ADC HBM9033

Under the terms of the agreement, Nona Biosciences will receive a total of up to $53 million in upfront and near-term payments, with the potentia...

December 15, 2023 | News

Modalis and JCR Pharmaceuticals enter into joint research agreement

Modalis Therapeutics Corporation (Modalis) (Tokyo Stock Exchange: 4883) announced that it has entered into a joint research agreement with JCR Pharma...

December 14, 2023 | News

Molecular Loop Biosciences Secures $1.8M to Expand Multi-pathogen Genomics for Respiratory Infections

"This grant from the foundation will support our commitment to expanding access to NGS with LoopCap™ technology. LoopCap addresses challenges in...

December 14, 2023 | News

MGI Broadens Latin American Presence with Genos Médica and TCL Group Partnerships

"Over the last four years, we have witnessed rapid growth in the high-throughput sequencing market in Latin America and are confident in its upwa...

December 13, 2023 | News

Illumina and HaploX Collaborate on Benchtop Sequencing System

This marks a new stage in the strategic partnership between the two companies. In the future, Illumina and HaploX will take the localized manufacturing of ...

December 13, 2023 | News

Stay Connected